| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/17/1996 | CA2179403A1 Antifungal sordaridin derivatives |
| 05/15/1996 | EP0711785A1 Novel antitumor antibiotic compounds: hayumicins and analogs thereof |
| 05/15/1996 | EP0711783A1 Antifungal Sordarin derivatives |
| 05/15/1996 | EP0711778A1 Sunscreens, sunscreen compositions and use thereof |
| 05/15/1996 | EP0711774A1 Crystalline cephem-addition salts and process for their preparation |
| 05/15/1996 | EP0711771A2 Substituted-1,3-oxathiolanes with antiviral properties |
| 05/15/1996 | EP0711770A1 Antagonists of adhesion receptors |
| 05/15/1996 | EP0711769A1 Improved process for large-scale production of BMS 180048 and analogs |
| 05/15/1996 | EP0711767A1 Antineoplastic cyclolignan derivatives |
| 05/15/1996 | EP0711765A1 Immunosuppressive cyclolignan derivatives |
| 05/15/1996 | EP0711757A1 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists |
| 05/15/1996 | EP0711755A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 05/15/1996 | EP0711560A1 Pharmaceutical composition for the oral administration of flavonoids |
| 05/15/1996 | EP0711559A2 Use of phosphatidylserines for the manufacture of a medicament for improving cerebration |
| 05/15/1996 | EP0711558A1 Compositions for topical application to skin, hair and nails |
| 05/15/1996 | EP0711557A1 Base for formulating pharmaceutical agents |
| 05/15/1996 | EP0711556A1 Intravenous solutions containing staurosporine derivatives |
| 05/15/1996 | EP0711555A2 Enzyme inactivators |
| 05/15/1996 | EP0711554A1 Antidepressant |
| 05/15/1996 | EP0711553A1 Use of the Melatonin in the traetment of the articular symptoms of trheumatoid arthritis |
| 05/15/1996 | EP0711552A1 Dermatologic compositions containing wool wax acids and fatty acid glycerides against superinfections |
| 05/15/1996 | EP0711539A1 Use of a salicylic acid derivative as stabilizer of oil-in-water emulsion, surfactants-free |
| 05/15/1996 | EP0711503A2 Milk fortified with GLA and/or DGLA |
| 05/15/1996 | EP0711343A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 05/15/1996 | EP0711301A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 05/15/1996 | EP0711299A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS |
| 05/15/1996 | EP0711298A1 Activated macrolactams having immunomodulatory activities |
| 05/15/1996 | EP0711297A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 05/15/1996 | EP0711296A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 05/15/1996 | EP0711293A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents |
| 05/15/1996 | EP0711292A1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 05/15/1996 | EP0711291A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 05/15/1996 | EP0711290A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 05/15/1996 | EP0711289A1 Piperazine compounds used in therapy |
| 05/15/1996 | EP0711288A1 Piperazine derivatives as alpha 1a-adrenergic receptor antagonists |
| 05/15/1996 | EP0711287A1 Benzo-fused lactams promote release of growth hormone |
| 05/15/1996 | EP0711286A1 Benzoxazinones and benzothiazinones endowed with therapeutic activity |
| 05/15/1996 | EP0711284A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity |
| 05/15/1996 | EP0711283A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
| 05/15/1996 | EP0711281A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 05/15/1996 | EP0711280A1 Perhydroisoindole derivatives as p substance antagonists |
| 05/15/1996 | EP0711279A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists |
| 05/15/1996 | EP0711278A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents |
| 05/15/1996 | EP0711275A1 (thio)carbimidinic acid derivatives and medicaments containing the same |
| 05/15/1996 | EP0711272A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists |
| 05/15/1996 | EP0711271A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 05/15/1996 | EP0711177A1 Improvements relating to prodrugs |
| 05/15/1996 | EP0711175A1 Topical compositions for re-epitheliazation of persistent epithelial defects |
| 05/15/1996 | EP0711169A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 05/15/1996 | EP0711168A1 Methods of treating apoptosis and associated conditions |
| 05/15/1996 | EP0711167A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 05/15/1996 | EP0711166A1 Controlled release tacrine drug delivery systems and methods for preparing same |
| 05/15/1996 | EP0711165A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock |
| 05/15/1996 | EP0711163A1 Use of benzydamine in the treatment of pathological conditions caused by tnf |
| 05/15/1996 | EP0711162A1 Imidazole 5-position substituted angiotensin ii antagonists |
| 05/15/1996 | EP0711161A1 Method to inhibit restenosis |
| 05/15/1996 | EP0711160A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 05/15/1996 | EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
| 05/15/1996 | EP0711158A1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 05/15/1996 | EP0711157A1 Endothelin receptor antagonists |
| 05/15/1996 | EP0711156A1 Use of n-methyl-aspartic acid for enhancing growth and altering body composition |
| 05/15/1996 | EP0711155A1 Amino acid supplement |
| 05/15/1996 | EP0711154A1 Stabilized pharmaceutical composition containing bupropion |
| 05/15/1996 | EP0711152A1 Powder-layered oral dosage forms |
| 05/15/1996 | EP0711151A1 Particles with modified physicochemical properties, their preparation and uses |
| 05/15/1996 | EP0711149A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 05/15/1996 | EP0711140A1 Antifungal nail solution |
| 05/15/1996 | EP0711134A1 Medicinal for protection from neurological damage |
| 05/15/1996 | EP0682522B1 Process to prepare pharmaceutical compositions containing vecuronium bromide |
| 05/15/1996 | EP0679153A4 Amino acids and peptides having modified terminals. |
| 05/15/1996 | EP0639192B1 (benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
| 05/15/1996 | EP0625898B1 Liposomal piroxicam formulations |
| 05/15/1996 | EP0620828A4 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof. |
| 05/15/1996 | EP0557404B1 ANTIVIRAL USE OF A 2,6-DI-t-BUTYLPHENOL COMPOUND SUBSTITUTED IN POSITION 4, PARTICULARLY IN RELATION TO HERPESVIRUSES AND PAPILLOMAVIRUSES |
| 05/15/1996 | EP0519983B1 Use of ketorolac for treatment of periodontal disease |
| 05/15/1996 | EP0493408B1 Oral anticoagulant/platelet inhibitor low dose formulation |
| 05/15/1996 | EP0479867B1 Compositions useful as contraceptives in males |
| 05/15/1996 | EP0465565B1 Treatment of aids dementia, myelopathy and blindness |
| 05/15/1996 | EP0456835B1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof |
| 05/15/1996 | DE4440563A1 Nicotine-contg. media and perfume ointments as substitute for smoking |
| 05/15/1996 | DE4440193A1 Verwendung von Dioxomorpholinen zur Bekämpfung von Endoparasiten, neue Dioxomorpholine und Verfahren zur ihrer Herstellung Use of Dioxomorpholinen for controlling endoparasites, new Dioxomorpholine and methods for their preparation |
| 05/15/1996 | DE4439947A1 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel 2,2-Dichloralkancarbonsäuren, processes for their preparation and pharmaceutical compositions containing them |
| 05/15/1996 | DE19541689A1 Medicament contg. ciclesonid and beta2-sympathomimetic |
| 05/15/1996 | CN1122601A |1,2,4¨triazolo|4,3-a¨ quinoxaline derivatives, their preparation and use |
| 05/15/1996 | CN1122600A Second messenger cell signaling inhibitors |
| 05/15/1996 | CN1122599A 8-substituted xanthines as selective adenosine receptor agents |
| 05/15/1996 | CN1122571A High dose formulations |
| 05/15/1996 | CN1122570A Use of granisetron for the treatment of post-operative nausea and vomiting |
| 05/15/1996 | CN1122569A Transdermal therapeutic system containing estradiol |
| 05/15/1996 | CN1122565A Pour-on formulations containing polymeric material, glycols and glycerides |
| 05/15/1996 | CN1122338A Physical form of dihydro-2,3-benzodiazepine derivative |
| 05/15/1996 | CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid |
| 05/15/1996 | CN1122336A Saccharin zinc and its producing process |
| 05/15/1996 | CN1122331A Benzene, pyridine and pyrimidine derivative |
| 05/15/1996 | CN1122329A Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 05/15/1996 | CN1122248A Insulin analog formulations |
| 05/15/1996 | CN1122247A Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment |
| 05/15/1996 | CN1122226A Tablet, capsule, or granule comprising desogestrel |
| 05/15/1996 | CN1122225A Ophthalmic suspension containing diflupredonate |